Nicholas P. Clayton

Dimorphic Effects of Transforming Growth Factor-β Signaling During Aortic Aneurysm Progression in Mice Suggest a Combinatorial Therapy for Marfan Syndrome

Jason Cook, Nicholas P. Clayton, Luca Carta et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2015 · 216 citations · Full text

Morpholino-mediated Knockdown of DUX4 Toward Facioscapulohumeral Muscular Dystrophy Therapeutics

Jennifer C. J. Chen, Oliver D. King, Nicholas P. Clayton et al. · Molecular Therapy · 2016 · 112 citations · Full text

Inhibiting TGF-β Activity Improves Respiratory Function in mdx Mice

Carol A. Nelson, R. Bridge Hunter, Lindsay A. Quigley et al. · American Journal Of Pathology · 2011 · 73 citations · Full text

Inflammation, Inflammatory Lung Disease, Mdx Mice +7

Antisense Oligonucleotide-mediated Suppression of Muscle Glycogen Synthase 1 Synthesis as an Approach for Substrate Reduction Therapy of Pompe Disease

Nicholas P. Clayton, Carol A. Nelson, Timothy Weeden et al. · Molecular Therapy — Nucleic Acids · 2014 · 70 citations · Full text

Immunology, Molecular Biology, Substrate Reduction Therapy +23

Systemic Delivery of a Peptide-Linked Morpholino Oligonucleotide Neutralizes Mutant RNA Toxicity in a Mouse Model of Myotonic Dystrophy

Andrew J. Leger, Leocadia M. Mosquea, Nicholas P. Clayton et al. · Nucleic Acid Therapeutics · 2013 · 56 citations

Genetics, Toxic Effects, Molecular Biology +16